Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	707	200	199	635	320	-
Market Cap Growth	200.44%	0.34%	-68.65%	98.76%	-	-
Enterprise Value	612.4	79.41	47.24	450.53	178.17	-45.21
Last Close Price	4.12	1.45	1.56	5.03	3.17	-
PE Ratio	-	-4.03	-4.73	-13.59	-2.42	0
PS Ratio	-	235.10	-	-	-	-
PB Ratio	6.04	1.60	1.34	3.50	2.28	0
P/TBV Ratio	6.10	1.59	1.33	2.91	1.42	-
P/FCF Ratio	-	-4.45	-4.90	-18.50	-15.05	0
P/OCF Ratio	-	-4.46	-4.90	-18.62	-16.25	0
EV/Sales Ratio	-	93.43	-	-	-	-
EV/EBITDA Ratio	-	-1.45	-0.97	-11.33	-2.22	1.78
EV/EBIT Ratio	-	-1.40	-0.94	-10.82	-2.18	1.63
EV/FCF Ratio	-	-1.77	-1.16	-13.12	-8.39	1.68
Debt / Equity Ratio	0.10	0.05	0.00	0.01	0.02	0.05
Debt / EBITDA Ratio	-0.15	-0.12	-0.04	-0.07	-0.05	-0.37
Debt / FCF Ratio	-0.22	-0.15	-0.04	-0.08	-0.19	-0.35
Asset Turnover	0	0.01	0	0	0	0
Quick Ratio	7.28	14.28	19.54	11.54	13.59	4.66
Current Ratio	7.66	14.96	19.73	12.05	13.84	4.97
Return on Equity (ROE)	-56.79%	-36.07%	-25.74%	-24.38%	-91.30%	75.01%
Return on Assets (ROA)	-52.78%	-38.10%	-28.25%	-23.57%	-79.63%	-67.67%
Return on Capital (ROIC)	-723.14%	-929.73%	-993.16%	-612.93%	-973.80%	-287.20%
Return on Capital Employed (ROCE)	-57.90%	-40.36%	-30.29%	-25.51%	-88.55%	-89.18%
Earnings Yield	-8.82%	-24.83%	-21.15%	-7.36%	-41.32%	-
FCF Yield	-6.44%	-22.47%	-20.41%	-5.40%	-6.64%	-
Buyback Yield / Dilution	0.00%	-8.95%	-1.52%	-12.00%	-40.13%	-
Total Shareholder Return	-	-8.95%	-1.52%	-12.00%	-40.13%	-

Updated Aug 11, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q